Oncotelic Therapeutics Inc. (OTLC)
Market Closed
16 Oct, 08:00 PM
OTC PINK OTC PINK Primary $
0. 02
0
0%
$
8.78M Market Cap
- P/E Ratio
- Div Yield
385,800 Volume
0 Eps
$ 0.02
Previous Close Want to track OTLC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oncotelic Therapeutics Inc. (OTLC) Statistics
Valuation metrics
Market Cap 8.78M
Enterprise value 15.97T
Trailing P/E (ttm) 0.03
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 36.6
Price/Book (mrq) 0
Enterprise Value/Revenue 63,876,976.6
Enterprise Value/EBITDA 46.47
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 464.21K
Average volume (90 days) 282.98K
Price summary
52-Week low 0.02
52-Week high 0.11
Beta -
50-Day moving average 0.03
200-Day moving average 0.04
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:12
Last split Date 28 Dec 2012
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 989.98%
Operating margin -22.87%
Operational effectiveness
Return on assets 0%
Return on equity 0%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.55
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 415.78
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 0.08%
Book value per share (mrq) 588,840.04
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
